BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 14645429)

  • 21. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987-2004) from the childhood cancer registry of the Rhône-Alpes region (ARCERRA) in France.
    Berger C; Trombert-Paviot B; Casagranda L; Mialou V; Frappaz D; Plantaz D; Collardeau-Frachon S; Freycon F
    Pediatr Hematol Oncol; 2011 Aug; 28(5):364-79. PubMed ID: 21736475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.
    van Leeuwen FE; Klokman WJ; Veer MB; Hagenbeek A; Krol AD; Vetter UA; Schaapveld M; van Heerde P; Burgers JM; Somers R; Aleman BM
    J Clin Oncol; 2000 Feb; 18(3):487-97. PubMed ID: 10653864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
    van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
    J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second neoplasms after megavoltage radiation for pediatric tumors.
    Gold DG; Neglia JP; Dusenbery KE
    Cancer; 2003 May; 97(10):2588-96. PubMed ID: 12733158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence.
    Green DM; Hyland A; Barcos MP; Reynolds JA; Lee RJ; Hall BC; Zevon MA
    J Clin Oncol; 2000 Apr; 18(7):1492-9. PubMed ID: 10735897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
    Bassal M; Mertens AC; Taylor L; Neglia JP; Greffe BS; Hammond S; Ronckers CM; Friedman DL; Stovall M; Yasui YY; Robison LL; Meadows AT; Kadan-Lottick NS
    J Clin Oncol; 2006 Jan; 24(3):476-83. PubMed ID: 16421424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
    Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.
    Beaty O; Hudson MM; Greenwald C; Luo X; Fang L; Wilimas JA; Thompson EI; Kun LE; Pratt CB
    J Clin Oncol; 1995 Mar; 13(3):603-9. PubMed ID: 7884422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
    Swerdlow AJ; Barber JA; Hudson GV; Cunningham D; Gupta RK; Hancock BW; Horwich A; Lister TA; Linch DC
    J Clin Oncol; 2000 Feb; 18(3):498-509. PubMed ID: 10653865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
    Goldsby R; Burke C; Nagarajan R; Zhou T; Chen Z; Marina N; Friedman D; Neglia J; Chuba P; Bhatia S
    Cancer; 2008 Nov; 113(9):2597-604. PubMed ID: 18823030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
    Meadows AT; Friedman DL; Neglia JP; Mertens AC; Donaldson SS; Stovall M; Hammond S; Yasui Y; Inskip PD
    J Clin Oncol; 2009 May; 27(14):2356-62. PubMed ID: 19255307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.
    Bhatia S; Sather HN; Pabustan OB; Trigg ME; Gaynon PS; Robison LL
    Blood; 2002 Jun; 99(12):4257-64. PubMed ID: 12036851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Second Primary Tumors After Childhood and Adolescent Ovarian Malignancies: A SEER Analysis (1973-2011).
    Nasioudis D; Ramer I; Sisti G; Fambrini M
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):522-5. PubMed ID: 26152647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
    J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan.
    Teng CJ; Huon LK; Hu YW; Yeh CM; Chien SH; Chen SC; Liu CJ
    PLoS One; 2016; 11(4):e0152909. PubMed ID: 27035574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.